Patent ID: 9635862
Date: 2017-05-02
CPC Classifications: A01N,C12N,C12R

Claim:
1. A process of inhibiting microbial biofilm formation, said process comprising a step of bringing into contact biofilm producing microbial cells and a preparation consisting of partially purified extracellular metabolites of probiotic bacterial strain Bacillus coagulans deposited under accession number MTCC 5856, prepared by partially purifying a culture supernatant of said Bacillus coagulans strain, alone or combined with a composition comprising from about 61% w/w of thymol, about 38% w/w of monolaurin, and about 1% w/w of magnolol obtained from supercritical fluid extracts of Magnolia officinalis , thereby inhibiting said biofilm formation.